Forecast Ledgerinterventional psychiatry and psychedelic medicineQuoted, dated predictions scored against public outcomes under one written method. Every score links to the words, the rule and the evidence.

Not admitted · Commitment (own venture)

Rules 1.1.0 · as of 14 Sep 2026

Rick Doblin · Said 4 Sep 2025 · doblin-0236

Quote

Commitment (own venture)

“Lykos will continue negotiations with the FDA. MAPS will keep driving forward: incubating and accelerating new MDMA-focused research, training therapists around the globe, catalyzing humanitarian projects in high trauma/low resource areas of the world, and building the infrastructure for a future where psychedelic-assisted healing and personal growth are not delayed by shifting politics, but delivered as a matter of compassion and justice.”
· MAPS Statement on FDA's Public Release of Complete Response Letter for MDMA-assisted Therapy · article

Same CRL-release statement. Doblin states Lykos will keep negotiating with FDA and lists MAPS' forward program.

The forecaster's own organization can make the outcome happen by its own decision: clinic openings, product launches, hires, trial starts, filings by their own company. Listed in the commitments table, never scored.

← Earlier · Later → · All statements